Organogenesis Holdings (ORGO) Work In Process (2021 - 2026)
Organogenesis Holdings' (ORGO) quarterly Work In Process came in at $962000.0 in Q1 2026, up 14.93% year-on-year from $837000.0 in Q1 2025, and down 23.95% quarter-over-quarter from $1.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Work In Process (2021 - 2026) Analysis & Trends
Organogenesis Holdings' Work In Process history runs 6 years deep, the most recent figure standing at $962000.0 for Q1 2026.
- On a quarterly basis, Work In Process rose 14.93% year-over-year to $962000.0 in Q1 2026; TTM through Mar 2026 was $962000.0, a 14.93% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 37.05% from the prior year.
- Work In Process declined to $962000.0 in Q1 2026 per ORGO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Work In Process topped out at $1.7 million in Q2 2023 and bottomed at $810000.0 in Q4 2023.
- The 5-year median for Work In Process is $1.0 million (2022), against an average of $1.1 million.
- Across the five-year window, Work In Process soared 64.94% in 2023 and tumbled 50.67% in 2024, its largest moves.
- Year by year, Work In Process stood at $1.0 million in 2022, then fell by 20.74% to $810000.0 in 2023, then climbed by 13.95% to $923000.0 in 2024, then soared by 37.05% to $1.3 million in 2025, then decreased by 23.95% to $962000.0 in 2026.
- Per Business Quant, the three latest ORGO Work In Process figures stand at $962000.0 (Q1 2026), $1.3 million (Q4 2025), and $1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 962,000.00 |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 825,000.00 |
| Mar 31, 2025 | 837,000.00 |
| Dec 31, 2024 | 923,000.00 |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 847,000.00 |
| Mar 31, 2024 | 858,000.00 |
| Dec 31, 2023 | 810,000.00 |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.04 Mn |
| Dec 31, 2021 | 991,000.00 |